Home › AdComm
FDA advisory committee calendar
Upcoming FDA advisory committee (AdComm) meetings that review biotech drugs and biologics — the panel vote that often moves the stock more than the PDUFA itself. Sourced from FDA Federal Register notices. Meetings are announced ~4–6 weeks ahead, so this fills in as the FDA schedules them.
Scheduled meetings
CTGTACCAPR · Jul 29, 2026Deramiocel (CAP-1002) — Duchenne muscular dystrophy (DMD)CTGTACREPL · Jul 30, 2026Vusolimogene oderparepvec (RP1) + nivolumab — Advanced melanoma
Primary source: the FDA Advisory Committee Calendar. AdComm votes are advisory; the FDA makes the final decision at the PDUFA date.
Not affiliated with or endorsed by the FDA. Informational and educational only — not investment advice. Verify against FDA Federal Register notices. © 2026 pdufa.bio